Jonathan Javitt is the founder of NRx Pharmaceuticals. Latest round: IPO. Based in Wilmington, Delaware.
Jonathan C. Javitt is the Founder, Chairman, and CEO of NRx Pharmaceuticals, a clinical-stage biopharma company focused on neuroscience and mental health treatments. He leads the development of innovative therapeutics like preservative-free ketamine (KETAFREE™) for suicidal ideation and NRX-101 for suicidal bipolar depression.
Full founder directory · Investor directory · Company funding database · Fundraising library